Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Catherine G Gallagher"'
Publikováno v:
Int J Exerc Sci
The American Fitness Industry has seen progressive success with recent increases in facility memberships and annual revenues of fitness centers. The number of fitness trainers and instructors in the United States has persisted this growth and is proj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::05701c9d7a18abb5e19aa3726f05b5c4
https://europepmc.org/articles/PMC8136576/
https://europepmc.org/articles/PMC8136576/
Autor:
Daniel T. Cohen, Silvia Escudero, Catherine G Gallagher, Thomas E. Wales, John R. Engen, Loren D. Walensky, Susan Lee, Annissa J. Huhn, Nicole A. Cohen, James Luccarelli, Gregory H. Bird
Publikováno v:
Nature structural & molecular biology
MCL-1 is an antiapoptotic BCL-2 family protein that has emerged as a major pathogenic factor in human cancer. Like BCL-2, MCL-1 bears a surface groove whose function is to sequester the BH3 killer domains of proapoptotic BCL-2 family members, a mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee3006f3ab768370c7209b2d81f4627e
https://doi.org/10.1038/nsmb.3223
https://doi.org/10.1038/nsmb.3223
Autor:
Nicole A. Cohen, Catherine G Gallagher, James Luccarelli, Annissa J. Huhn, Silvia Escudero, Thomas E. Wales, Danny Cohen, John R. Engen, Gregory H. Bird, Susan Lee, Loren D. Walensky
Publikováno v:
Cancer Research. 76:3553-3553
MCL-1 is an anti-apoptotic BCL-2 family protein that has emerged as a major pathogenic factor across a broad range of human cancers. Thus, pharmacologic inhibition of MCL-1 has been the focus of intensive drug development efforts. Like BCL-2, MCL-1 b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d16c324a573b2f1b05b0f52dcb35417f
https://doi.org/10.1158/1538-7445.am2016-3553
https://doi.org/10.1158/1538-7445.am2016-3553